CompletedPhase 1NCT03635450

Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE

Studying Neonatal hypoxic and ischemic brain injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Joanne Kurtzberg, MD
Principal Investigator
Michael Cotten, MD
Duke University
Intervention
Infusion of hCT-MSC(biological)
Enrollment
6 enrolled
Eligibility
All sexes
Timeline
20182020

Study locations (1)

Collaborators

Duke Clinical and Translational Science Institute (CTSI), part of the NIH Clinical and Translational Science Awards (CTSA)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03635450 on ClinicalTrials.gov

Other trials for Neonatal hypoxic and ischemic brain injury

Additional recruiting or active studies for the same condition.

See all trials for Neonatal hypoxic and ischemic brain injury

← Back to all trials